Mesoblast | MSB - Interest Expense On Debt


Mesoblast reported $11.29M in Interest Expense on Debt for its fiscal semester ending in December of 2025.





Interest Expense On Debt Change Date
Avita Medical AUD 1.25M 100K Jun/2025
Clinuvel Pharmaceuticals AUD 2.49M 51.97K Jun/2025
Cochlear AUD 6.3M 3.65M Dec/2025
CSL USD 215M 111M Dec/2025
Paradigm Biopharmaceuticals AUD 1000 3K Jun/2025
PYC Therapeutics AUD 17K 11K Jun/2025
Ramsay Health Care AUD 300.6M 15.5M Dec/2025
Sonic Healthcare AUD 86.91M 43.94M Dec/2024
Telix Pharmaceuticals AUD 19.39M 11.77M Jun/2026